Advertisement
Screener

Lantern Pharma Inc. (LTRN) Shares Issued

2.8 / 5 stars · 68/120 Roast Me

Lantern Pharma Inc. Shares Issued

Lantern Pharma Inc. (LTRN) had Shares Issued of 12.76 million shares as of 2026-06-30, per its 10-Q filed 2026-08-14.

Financial Statements › Balance Sheet › Equity › Stockholders' Equity, Number of Shares, Par Value and Other Disclosure › Common Stock, Number of Shares, Par Value and Other Disclosure

us-gaap:CommonStockSharesIssued · last filed 2026-08-14

  • 2026-06-30: Common Stock, Shares, Issued 12.76M shares.
  • 2026-03-31: Common Stock, Shares, Issued 11.25M shares.
  • 2025-12-31: Common Stock, Shares, Issued 11.25M shares.
  • 2025-09-30: Common Stock, Shares, Issued 11.04M shares.
Period endCommon Stock, Shares, Issued
2026-06-3012.76M shares
10-Q · filed 2026-08-14
2026-03-3111.25M shares
10-Q · filed 2026-05-15
2025-12-3111.25M shares
10-Q · filed 2026-08-14
2025-09-3011.04M shares
10-Q · filed 2025-11-12
2025-06-3010.78M shares
10-Q · filed 2025-08-13
2025-03-3110.78M shares
10-Q · filed 2025-05-15
2024-12-3110.78M shares
10-K · filed 2026-03-30
2024-09-3010.78M shares
10-Q · filed 2024-11-07
2024-06-3010.76M shares
10-Q · filed 2024-08-08
2024-03-3110.76M shares
10-Q · filed 2024-05-09
2023-12-3110.72M shares
10-K · filed 2025-03-27
2023-09-3010.87M shares
10-Q · filed 2023-11-08
2023-06-3010.87M shares
10-Q · filed 2023-08-09
2023-03-3110.86M shares
10-Q · filed 2023-05-09
2022-12-3110.86M shares
10-K · filed 2024-03-18
2022-09-3010.86M shares
10-Q · filed 2022-11-07
2022-06-3010.83M shares
10-Q · filed 2022-08-08
2022-03-3110.83M shares
10-Q · filed 2022-05-03
2021-12-3111.09M shares
10-K · filed 2023-03-20
2021-09-3011.19M shares
10-Q · filed 2021-11-01
2021-06-3011.18M shares
10-Q · filed 2021-07-29
2021-03-3111.18M shares
10-Q · filed 2021-05-03
2020-12-316.22M shares
10-K · filed 2022-03-10
2020-09-306.22M shares
10-Q · filed 2020-10-29
2020-06-306.22M shares
10-Q · filed 2020-07-30
2019-12-311.98M shares
10-K · filed 2021-03-10

Similar stocks

Stock NameCountryMarket CapPE Ratio
Citius Pharmaceuticals, Inc. (CTXR)United States$0.016B-133.06
Anebulo Pharmaceuticals, Inc. (ANEB)United States$0.015B
Korsana Biosciences, Inc. (CYCN)United States$0.016B
ACTUATE THERAPEUTICS, INC. (ACTU)United States$0.015B
Tvardi Therapeutics, Inc. (TVRD)United States$0.014B
Vyome Holdings, Inc (HIND)United States$0.014B-1.38
BullFrog AI Holdings, Inc. (BFRG)United States$0.014B
Pasithea Therapeutics Corp. (KTTA)United States$0.017B-0.81
Allarity Therapeutics, Inc. (ALLR)United States$0.017B-1.66
LISATA THERAPEUTICS, INC. (LSTA)United States$0.014B-2.13